On May 31, the Financial Research Center of 300033, an investor asked Yisheng Pharmaceutical (002566), Hello: Li Tiejun, a shareholder in the company's top ten outstanding shares, or an executive of the company? If it's an executive, he buys company stock as if he didn't see the normal message prompt? Thank you
The company replied that hello, li Tiejun, a circulating shareholder, has submitted his resignation report to the board of directors of the company on March 3, 2017, and resigned as deputy general manager and secretary of the board of directors.
This article originated from the Flush Financial Research Center